<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="MEDLINE" Owner="NLM">        <PMID Version="1">30187675</PMID>        <DateCompleted>            <Year>2018</Year>            <Month>09</Month>            <Day>18</Day>        </DateCompleted>        <DateRevised>            <Year>2018</Year>            <Month>11</Month>            <Day>14</Day>        </DateRevised>        <Article PubModel="Print">            <Journal>                <ISSN IssnType="Electronic">1349-7006</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>109</Volume>                    <Issue>9</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>Sep</Month>                    </PubDate>                </JournalIssue>                <Title>Cancer science</Title>                <ISOAbbreviation>Cancer Sci.</ISOAbbreviation>            </Journal>            <ArticleTitle>Clinical practice guidance for next-generation sequencing in cancer diagnosis and treatment (Edition 1.0).</ArticleTitle>            <Pagination>                <MedlinePgn>2980-2985</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.1111/cas.13730</ELocationID>            <Abstract>                <AbstractText>In Japan, the social (medical) health-care system is on the way to being developed to advance personalized medicine through the implementation of cancer genomic medicine, known as &quot;cancer clinical sequencing,&quot; which uses a next-generation sequencer. However, no Japanese guidance for cancer genomic testing exists. Gene panel testing can be carried out to help determine patient treatment, confirm diagnosis, and evaluate prognostic predictions of patients with mainly solid cancers for whom no standard treatment is available. This guidance describes how to utilize gene panel testing according to the type of cancer: childhood cancer, rare cancer, carcinoma of unknown primary, and other cancers. The level of evidence classification for unified use in Japan is also detailed. This guidance establishes the basic principles of the quality control of specimens, requirements of medical institutions, informed consent, handling of data during the postanalysis stage, and treatment options based on the evidence level. In Japan, gene panel testing for cancer treatment and diagnosis is recommended to comply with this guidance. This is a collaborative work of the Japanese Society of Medical Oncology, Japan Society of Clinical Oncology, and the Japanese Cancer Association.</AbstractText>                <CopyrightInformation>Â© 2018 The Authors. Cancer Science published by John Wiley &amp; Sons Australia, Ltd on behalf of Japanese Cancer Association.</CopyrightInformation>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Sunami</LastName>                    <ForeName>Kuniko</ForeName>                    <Initials>K</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Takahashi</LastName>                    <ForeName>Hideaki</ForeName>                    <Initials>H</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Kashiwa, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Tsuchihara</LastName>                    <ForeName>Katsuya</ForeName>                    <Initials>K</Initials>                    <AffiliationInfo>                        <Affiliation>Division of Translational Informatics, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Takeda</LastName>                    <ForeName>Masayuki</ForeName>                    <Initials>M</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Medical Oncology, Kindai University, Faculty of Medicine, Osaka, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Suzuki</LastName>                    <ForeName>Tatsuya</ForeName>                    <Initials>T</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Hematology, National Cancer Center Hospital, Tokyo, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Naito</LastName>                    <ForeName>Yoichi</ForeName>                    <Initials>Y</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Breast and Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Sakai</LastName>                    <ForeName>Kazuko</ForeName>                    <Initials>K</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Genome Biology, Kindai University, Faculty of Medicine, Osaka, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Dosaka-Akita</LastName>                    <ForeName>Hirotoshi</ForeName>                    <Initials>H</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Medical Oncology, Hokkaido University Graduate School of Medicine, Hokkaido, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Ishioka</LastName>                    <ForeName>Chikashi</ForeName>                    <Initials>C</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Medical Oncology, Tohoku University Hospital, Miyagi, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Kodera</LastName>                    <ForeName>Yasuhiro</ForeName>                    <Initials>Y</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Gastroenterological Surgery, Nagoya University Graduate School of Medicine, Aichi, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Muto</LastName>                    <ForeName>Manabu</ForeName>                    <Initials>M</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Therapeutic Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Wakai</LastName>                    <ForeName>Toshifumi</ForeName>                    <Initials>T</Initials>                    <AffiliationInfo>                        <Affiliation>Division of Digestive and General Surgery, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Yamazaki</LastName>                    <ForeName>Kentaro</ForeName>                    <Initials>K</Initials>                    <AffiliationInfo>                        <Affiliation>Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Yasui</LastName>                    <ForeName>Wataru</ForeName>                    <Initials>W</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Molecular Pathology, Hiroshima University, Hiroshima, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Bando</LastName>                    <ForeName>Hideaki</ForeName>                    <Initials>H</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Fujimoto</LastName>                    <ForeName>Yumi</ForeName>                    <Initials>Y</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Breast and Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Fukuoka</LastName>                    <ForeName>Shota</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Harano</LastName>                    <ForeName>Kenichi</ForeName>                    <Initials>K</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Breast and Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Kawazoe</LastName>                    <ForeName>Akihito</ForeName>                    <Initials>A</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Kimura</LastName>                    <ForeName>Gen</ForeName>                    <Initials>G</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Kashiwa, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Koganemaru</LastName>                    <ForeName>Shigehiro</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Experimental Therapeutics, National Cancer Center Hospital East, Kashiwa, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Kogawa</LastName>                    <ForeName>Takahiro</ForeName>                    <Initials>T</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Breast and Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Kotani</LastName>                    <ForeName>Daisuke</ForeName>                    <Initials>D</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Kuboki</LastName>                    <ForeName>Yasutoshi</ForeName>                    <Initials>Y</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Experimental Therapeutics, National Cancer Center Hospital East, Kashiwa, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Matsumoto</LastName>                    <ForeName>Hiroshi</ForeName>                    <Initials>H</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Matsumoto</LastName>                    <ForeName>Shingo</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Mishima</LastName>                    <ForeName>Saori</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Nakamura</LastName>                    <ForeName>Yoshiaki</ForeName>                    <Initials>Y</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Sawada</LastName>                    <ForeName>Kentaro</ForeName>                    <Initials>K</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Shingaki</LastName>                    <ForeName>Sumito</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Experimental Therapeutics, National Cancer Center Hospital East, Kashiwa, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Shitara</LastName>                    <ForeName>Kohei</ForeName>                    <Initials>K</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Umemoto</LastName>                    <ForeName>Kumiko</ForeName>                    <Initials>K</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Kashiwa, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Umemura</LastName>                    <ForeName>Shigeki</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Yasuda</LastName>                    <ForeName>Kayo</ForeName>                    <Initials>K</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Yoshino</LastName>                    <ForeName>Takayuki</ForeName>                    <Initials>T</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Yamamoto</LastName>                    <ForeName>Noboru</ForeName>                    <Initials>N</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Nishio</LastName>                    <ForeName>Kazuto</ForeName>                    <Initials>K</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Genome Biology, Kindai University, Faculty of Medicine, Osaka, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <CollectiveName>Japanese Society of Medical Oncology</CollectiveName>                </Author>                <Author ValidYN="Y">                    <CollectiveName>Japan Society of Clinical Oncology</CollectiveName>                </Author>                <Author ValidYN="Y">                    <CollectiveName>Japanese Cancer Association</CollectiveName>                </Author>            </AuthorList>            <Language>eng</Language>            <GrantList CompleteYN="Y">                <Grant>                    <GrantID>H30-17</GrantID>                    <Agency>Health Labour Sciences Special Research Grant</Agency>                    <Country/>                </Grant>                <Grant>                    <Agency>Japanese Society of Medical Oncology</Agency>                    <Country/>                </Grant>                <Grant>                    <Agency>Japan Society of Clinical Oncology</Agency>                    <Country/>                </Grant>                <Grant>                    <Agency>Japanese Cancer Association</Agency>                    <Country/>                </Grant>            </GrantList>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>        </Article>        <MedlineJournalInfo>            <Country>England</Country>            <MedlineTA>Cancer Sci</MedlineTA>            <NlmUniqueID>101168776</NlmUniqueID>            <ISSNLinking>1347-9032</ISSNLinking>        </MedlineJournalInfo>        <CitationSubset>IM</CitationSubset>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>Genet Med. 2017 Feb;19(2):249-255</RefSource>                <PMID Version="1">27854360</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Mol Diagn. 2017 Jan;19(1):4-23</RefSource>                <PMID Version="1">27993330</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <MeshHeadingList>            <MeshHeading>                <DescriptorName UI="D059014" MajorTopicYN="Y">High-Throughput Nucleotide Sequencing</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D007258" MajorTopicYN="N">Informed Consent</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName>                <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>                <QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D017410" MajorTopicYN="Y">Practice Guidelines as Topic</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D011786" MajorTopicYN="N">Quality Control</DescriptorName>            </MeshHeading>        </MeshHeadingList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">evidence level</Keyword>            <Keyword MajorTopicYN="N">gene panel testing</Keyword>            <Keyword MajorTopicYN="N">guidance</Keyword>            <Keyword MajorTopicYN="N">next-generation sequencing</Keyword>            <Keyword MajorTopicYN="N">solid cancer</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>04</Month>                <Day>16</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="revised">                <Year>2018</Year>                <Month>06</Month>                <Day>18</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>06</Month>                <Day>21</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>9</Month>                <Day>7</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>9</Month>                <Day>7</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>9</Month>                <Day>19</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30187675</ArticleId>            <ArticleId IdType="doi">10.1111/cas.13730</ArticleId>            <ArticleId IdType="pmc">PMC6125473</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>